Wound infection can delay wound healing, significantly increasing costs and negatively impacting the patient’s quality of life. Studies have also shown that in non-healing wounds, antibiotic therapy has been provided without clear clinical justification and often without any clinical benefit, increasing the risk of Antimicrobial Resistance (AMR).1,2 The IWII Wound Infection Continuum is a well acknowledged educational tool that provides a framework to conceptualise the impact that microorganisms have on the host, the wound and on wound healing.3 Early intervention supports the use of proactive interventions in chronic wounds with a high risk of infection during the contamination and colonisation stages. This can prevent a wound infection from developing, promote wound healing, and reduce the risk of having to treat wounds with antibiotics.
Break the wound infection continuum
Use Sorbact Technology as an early intervention approach
Order your Cutimed® Sorbact® sample pack today!
Early intervention and the IWII Wound Infection Continuum
Early intervention encourages proactive management of chronic wounds that are at high risk of infection, particularly during the contamination and colonisation stages. This can help prevent wound infections from developing, lower the risk of needing antibiotic treatments and thereby promoting Antimicrobial Stewardship (AMS) strategies. Proactive early intervention with Cutimed Sorbact aims to break the wound infection continuum during the contamination and colonisation phases in wounds identified as being at high risk of infection.
At least 30% of antibiotics prescribed in the outpatient setting are unnecessary 5
The overuse of antibiotics in unsuitable cases has led to increasing antimicrobial resistance (AMR) and by 2050, it is predicted that AMR will be responsible for 10 million annual deaths worldwide.5 Sorbact® Technology can be used proactively to help break the wound infection continuum in the early stages and prevent a wound infection developing.
Safe infection prevention
Cutimed Sorbact binds bacteria and fungi with a purely physical mode of action. The bound microbes are inhibited and removed from the wound, preventing them from releasing endotoxins, enhancing wound healing. Antimicrobial resistance is not expected. A first line choice of dressing on a product formulary to prevent infection in contaminated and colonised wounds, and to treat wound infection.1
- Safe for the most delicate patients, from newborns to elderly
- Prevents and manages infected wounds
- Versatile, safe and easy to use
What's your role in preventing wound infection?
Antimicrobial Resistance (AMR) is a pressing global health and socioeconomic crisis already impacting health. If we don't act now, we could have 10 million deaths resulting from Antimicrobial Resistance (AMR) by 2050.5 Proactively treating the wound in the early stages can prevent the wound from becoming infected. Reducing infection is part of an Antimicrobial Stewardship strategy to reduce Antimicrobial Resistance.
The theme of the 2024 World Antimicrobial Resistance Awareness week was to educate, advocate and act now. Cutimed supported this initiative with a webinar featuring an expert panel of speakers to discuss various aspects of AMR. Learn more about our education support and how Sorbact® Technology dressings can help in the effort against AMR by requesting a sample pack today.
References
1. Tong QJ et al. Infect Drug Resist, 2018; 11: 417-25. Read more.
2. Edwards-Jones V. Wounds UK, 2018; 14(3): 46–51. Read more.
3. International Wound Infection, Institute (IWII) Wound Infection in Clinical Practice, Wounds International. 2022. Read more.
4. Stuermer E K et al. Clinical Performance and Safety of a Debridement Pad with Abrasive and Non-abrasive Fibres. J Wound Care. 2024; 33(6):408-416. Read more.
5. Fleming-Dutra K et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016;315:1864-1873. Read more.